Scleroderma is an autoimmune disease which causes hardening of the skin. This can result in a loss of mobility, and…
Articles by Patrícia Silva, PhD
Sine sclerosis, which is also known as sine scleroderma or systemic sclerosis sine scleroderma (ssSSc), is an extremely rare type of scleroderma. MORE: Research…
In honor of Scleroderma Awareness Month, we’re sharing some of our favourite …
Scleroderma is a condition that causes hardening of the skin and, in some cases, some organs in the body. Although the medical…
Today is the World Scleroderma Day, and to mark the occasion the Scleroderma Foundation is hosting a virtual “stepping…
Scleroderma is normally classified as an autoimmune rheumatic disease. According to scleroderma.org, the name of the disease itself comes from the…
Soin Neuroscience recently submitted an orphan drug application to the U.S. Food and Drug Administration (FDA) for the company’s investigational drug TV1001SR…
Cytori Therapeutics recently completed all 48-week follow-up visits in its STAR trial evaluating adipose-derived regenerative cells (ADRCs) for the treatment of…
Registration is open for the Scleroderma Foundation‘s 2017 National Patient Education Conference, July 21-23 in the Phoenix suburb of Chandler, Arizona.
Corbus Pharmaceuticals of Norwood, Mass., will commence a single Phase 3 clinical trial evaluating Anabasum (formerly known as Resunab or…